CLINICAL_TRIALS
trial_result
· 2024-02-08
Clinical Trial Update: A Study of IBI311 in Subjects With Active Thyroid Eye Disease [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial update for IBI311 in active thyroid eye disease has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Thyroid Eye Disease | Phase 2, Phase 3 | Status: COMPLETED